ICICI Prudential ELSS Tax Saver Fund
Akums Drugs and Pharmaceuticals Limited · NSE
13,98,828 sh · ₹92.09 Cr
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
1.9% of their portfolio
₹128.59 Cr
19,53,248 sh
Nippon India Pharma Fund
1.0% of their portfolio
₹92.52 Cr
14,05,283 sh
ICICI Prudential ELSS Tax Saver Fund
0.6% of their portfolio
₹92.09 Cr
13,98,828 sh
ICICI Prudential Equity & Debt Fund
0.1% of their portfolio
₹63.79 Cr
10,23,743 sh
ICICI Prudential Multi-Asset Fund
0.0% of their portfolio
₹27.76 Cr
5,29,339 sh
Groww Mutual Fund (scheme NI)
0.0% of their portfolio
₹4.05 L
615 sh
Groww Mutual Fund (scheme IB18)
0.0% of their portfolio
₹3.83 L
615 sh
FIIs raised their stake +0.5pp QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
ICICI Prudential ELSS Tax Saver Fund
Akums Drugs and Pharmaceuticals Limited · NSE
13,98,828 sh · ₹92.09 Cr
Nippon India Pharma Fund
Akums Drugs and Pharmaceuticals Limited · NSE
14,05,283 sh · ₹92.52 Cr
Groww Mutual Fund (scheme NI)
Akums Drugs and Pharmaceuticals Limited · NSE
615 sh · ₹4.05 L
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Akums Drugs and Pharmaceuticals Limited · NSE
19,53,248 sh · ₹128.59 Cr
Groww Mutual Fund (scheme IB18)
Akums Drugs and Pharmaceuticals Limited · NSE
615 sh · ₹3.83 L
ICICI Prudential ELSS Tax Saver Fund
Akums Drugs and Pharmaceuticals Limited · NSE
16,48,135 sh · ₹102.70 Cr
Nippon India Pharma Fund
Akums Drugs and Pharmaceuticals Limited · NSE
14,89,317 sh · ₹92.81 Cr
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Akums Drugs and Pharmaceuticals Limited · NSE
21,80,445 sh · ₹135.87 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
24 announcements on record for this company.
Promoter holding by quarter: Jun 2025 75.3%, Sep 2025 75.3%, Dec 2025 75.3%, Mar 2026 75.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— +0.2pp
FII holding by quarter: Jun 2025 4.2%, Sep 2025 2.3%, Dec 2025 1.1%, Mar 2026 1.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— −0.1pp
DII holding by quarter: Jun 2025 8.8%, Sep 2025 9.3%, Dec 2025 14.4%, Mar 2026 14.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— −0.3pp
MF holding by quarter: Jun 2025 6.7%, Sep 2025 6.4%, Dec 2025 11.2%, Mar 2026 10.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
ICICI Prudential Equity & Debt Fund
Akums Drugs and Pharmaceuticals Limited · NSE
10,23,743 sh · ₹63.79 Cr
ICICI Prudential Multi-Asset Fund
Akums Drugs and Pharmaceuticals Limited · NSE
5,29,339 sh · ₹27.76 Cr
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 75.3%, Sep 2025 75.3%, Dec 2025 75.3%, Mar 2026 75.3%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— +0.2pp
FII holding by quarter: Jun 2025 4.2%, Sep 2025 2.3%, Dec 2025 1.1%, Mar 2026 1.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— −0.1pp
DII holding by quarter: Jun 2025 8.8%, Sep 2025 9.3%, Dec 2025 14.4%, Mar 2026 14.4%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— −0.3pp
MF holding by quarter: Jun 2025 6.7%, Sep 2025 6.4%, Dec 2025 11.2%, Mar 2026 10.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
24 announcements on record for this company.